A new oral HER2-directed breast cancer therapy from Bayer AG, and its companion diagnostic from Thermo Fisher Scientific Inc.

Abbott Laboratories made plans to enter the cancer screening market with its reported acquisition of Exact Sciences Corp. The ...

Could GLP-1 receptor agonists (GLP-1RAs), already used in obesity and diabetes, be repurposed as drugs to slow aging? Hong ...

Tempest Therapeutics Inc. entered definitive agreements approved by its board to acquire certain dual-targeting CAR T ...

The limited efficacy of cancer immunotherapy is usually attributed to suboptimal antitumor T-cell generation, as well as ...

Success in Japan may further bolster Protara Therapeutics Inc. in its push with TARA-002 in pediatric patients with ...

Radiopharm Theranostics Ltd. has been granted Bellberry Human Research Ethics Committee (HREC) approval in Australia to ...

In a verbal sparring over who can deliver the lowest drug prices in the U.S., several Senate Democrats are urging President ...

Med-tech M&A activity cooled in October, with the total disclosed deal value reaching $1.68 billion, a step down from ...

Mabloc LLC has established a strategic partnership with Instituto Butantan to co-develop and manufacture MBL-YFV-01, a ...

In non-small-cell lung cancer (NSCLC) and various other cancers, mutations in nuclear factor erythroid 2-related factor 2 ...

Harbour Biomed is stepping up its antibody discovery process by using AI to develop innovative therapeutics. “We have done ...